NeuroVive Pharmaceutical AB Insider ownership
What is the Insider ownership of NeuroVive Pharmaceutical AB?
The Insider ownership of NeuroVive Pharmaceutical AB is 17.55%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Miscellaneous sector on LSE compared to NeuroVive Pharmaceutical AB
What does NeuroVive Pharmaceutical AB do?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Companies with insider ownership similar to NeuroVive Pharmaceutical AB
- Meteorite Capital has Insider ownership of 17.54%
- Distribution Finance Capital plc has Insider ownership of 17.54%
- Electro Optic Systems has Insider ownership of 17.55%
- Kuya Silver has Insider ownership of 17.55%
- Medgold Resources has Insider ownership of 17.55%
- HMN has Insider ownership of 17.55%
- NeuroVive Pharmaceutical AB has Insider ownership of 17.55%
- Ponce Inc has Insider ownership of 17.56%
- Valneva SE has Insider ownership of 17.57%
- Sichuan Expressway has Insider ownership of 17.57%
- Valneva SE has Insider ownership of 17.57%
- China Merchants Bank Co has Insider ownership of 17.57%
- Synaptogenix Inc has Insider ownership of 17.57%